TopoGEN, Inc.

Dedicated to Studies of Topoisomerase Enzymes

TopoGEN, Inc. provides innovative reagents and kits for topoisomerase research and mechanism-based drug development in cancer.

Kits are available to assay for topoisomerases (I, II, IV and gyrase) and Tdp1, to assay for topo inhibition in cells and to characterize topoisomerase inhibitors. DNA substrates, topo inhibitors, antibodies and kit replacement reagents are also available.

For a description of the Topoisomerase II Drug Screening Kit, one of Topogen’s most popular products, please see the featured video link:

Topoisomerase II Drug Screening Protocol in Theory and Practice

This feature offers tips and technical concepts to maximize and accelerate the pace of your Cancer Research Program.